Document Detail


Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain.
MedLine Citation:
PMID:  9262035     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Kadian/Kapanol (K) is a capsule formulation of morphine designed for 12- or 24-hourly dosing. This double-blind study compared the efficacy and safety of K every 24 hr to K every 12 hr and MS Contin tablets (MSC) every 12 hr. One hundred fifty-two patients with cancer pain were titrated to adequate analgesia with immediate-release morphine (IRM) solution. Stabilized patients were randonized to one of the three treatments for 7 +/- 1 days. Rescue medication was IRM tablets. Efficacy and safety were assessed by time to first remedication and total dose of rescue medication, pain scores, global assessments, and incidence of morphine-related side effects. Fifty-four patients were treated with K every 24 hr. 45 with K every 12 hr. and 53 with MSC every 12 hr. Mean age was 61 years and mean total daily dose of morphine was 138 mg. Forty-six percent of the K every 24 hr patients, 51% of the K every 12 hr patients, and 55% of the MSC every 12 hr patients required rescue medication on the final day. Time to remedication was 16.0 hr for K every 24 hr, 9.1 hr for K every 12 hr and 8.7 hr for MSC every 12 hr (P = 0.0010). Patient global assessment significantly favored K every 24 hr over MSC every 12 hr (P = 0.018). There were no statistically significant differences among the treatments for any morphine-related side effects when adjusted for baseline. K had efficacy and safety profiles similar to MSC every 12 hr but had the advantage of 12- or 24-hourly administration.
Authors:
A Broomhead; R Kerr; W Tester; P O'Meara; C Maccarrone; R Bowles; P Hodsman
Related Documents :
2240675 - Clinical evaluation of clonidine added to lidocaine solution for epidural anesthesia.
11251135 - Effect of preemptive multimodal analgesia for arthroscopic knee ligament repair.
16925195 - Combined preemptive and preventive analgesia in morbidly obese patients undergoing open...
15634825 - The effect of intra-articular methadone on postoperative pain following anterior crucia...
9726735 - The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on cl...
3113475 - Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in pos...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of pain and symptom management     Volume:  14     ISSN:  0885-3924     ISO Abbreviation:  J Pain Symptom Manage     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1997-09-11     Completed Date:  1997-09-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8605836     Medline TA:  J Pain Symptom Manage     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  63-73     Citation Subset:  IM    
Affiliation:
F.H. Faulding & Co. Limited, Adelaide, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Analgesics, Opioid / administration & dosage*,  therapeutic use
Delayed-Action Preparations
Double-Blind Method
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Morphine / administration & dosage*,  therapeutic use
Neoplasms / drug therapy*
Palliative Care*
Chemical
Reg. No./Substance:
0/Analgesics, Opioid; 0/Delayed-Action Preparations; 57-27-2/Morphine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chart recorder paper minder.
Next Document:  Cancer pain education among family physicians.